Last reviewed · How we verify
Oxygen gas
At a glance
| Generic name | Oxygen gas |
|---|---|
| Also known as | Praxair, ambulatory oxygen, O2 |
| Sponsor | Esbjerg Hospital - University Hospital of Southern Denmark |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Caracterization of the Combined Alterations in Respiration and aROUSal in Patients With Drug-resistant EpiLepsy (NA)
- SMILE Trial - Imaging Sub-Study
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- Gas Composition in the Hypopharynx During High-flow or Standard Oxygen Therapy Through Face Mask in Healthy Volunteers (NA)
- Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions
- Use of Nitrous Oxide for Pain and Anxiety Management During Cervical Cerclage Removal- A Multicenter Randomized Controlled Study (NA)
- Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (PHASE2)
- A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oxygen gas CI brief — competitive landscape report
- Oxygen gas updates RSS · CI watch RSS
- Esbjerg Hospital - University Hospital of Southern Denmark portfolio CI